JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.04B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.31B |
| 3 |
Apple
AAPL
|
+$746M |
| 4 |
Trane Technologies
TT
|
+$676M |
| 5 |
AABA
Altaba Inc
AABA
|
+$658M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.16B |
| 2 |
Honeywell
HON
|
+$701M |
| 3 |
iShares Russell Mid-Cap ETF
IWR
|
+$667M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$656M |
| 5 |
General Motors
GM
|
+$586M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.9% |
| 2 | Financials | 14.86% |
| 3 | Technology | 11.73% |
| 4 | Healthcare | 9.66% |
| 5 | Consumer Discretionary | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2451
Essential Utilities
WTRG
$11B
| $4.19M | ﹤0.01% |
125,805
-21,247
| -14% | -$697K |
2013 Q2
16 quarters
|
|
2452
Red Robin
RRGB
$158M
| $4.19M | ﹤0.01% |
64,170
+62,853
| +4,772% | +$3.99M |
2016 Q4
2 quarters
|
|
|
DPLO
2453
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $4.18M | ﹤0.01% |
282,622
+275,387
| +3,806% | +$4.59M |
2015 Q3
7 quarters
|
|
|
ZGNX
2454
DELISTED
Zogenix, Inc.
ZGNX
| $4.15M | ﹤0.01% |
286,299
+271,186
| +1,794% | +$3.41M |
2015 Q4
6 quarters
|
|
|
PDCE
2455
DELISTED
PDC Energy, Inc.
PDCE
| $4.15M | ﹤0.01% |
96,266
-45,698
| -32% | -$2.41M |
2013 Q2
16 quarters
|
|
2456
CALL
CubeSmart
CUBE
$8.5B
| $4.14M | ﹤0.01% |
172,248
-206,512
| -55% | -$5.23M |
2014 Q3
11 quarters
|
|
2457
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.19B
| $4.12M | ﹤0.01% |
102,465
-19,101
| -16% | -$768K |
2016 Q1
5 quarters
|
|
|
ENDP
2458
DELISTED
Endo International plc
ENDP
| $4.09M | ﹤0.01% |
366,023
-154,677
| -30% | -$1.82M |
2013 Q2
16 quarters
|
|
2459
Evogene
EVGN
$6.59M
| $4.08M | ﹤0.01% |
24,543
| – | – |
2016 Q1
5 quarters
|
|
|
KG
2460
Kestrel Group
KG
$43.1M
| $4.07M | ﹤0.01% |
18,343
-9,992
| -35% | -$2.33M |
2013 Q2
16 quarters
|
|
2461
Koppers
KOP
$870M
| $4.07M | ﹤0.01% |
112,621
-107,036
| -49% | -$4.12M |
2015 Q3
7 quarters
|
|
2462
Telkom Indonesia
TLK
$12.7B
| $4.07M | ﹤0.01% |
120,885
-703,352
| -85% | -$22.9M |
2013 Q2
16 quarters
|
|
2463
CALL
Deere & Co
DE
$184B
| $4.07M | ﹤0.01% |
32,900
-74,200
| -69% | -$8.71M |
2016 Q4
2 quarters
|
|
2464
iShares JPMorgan EM High Yield Bond ETF
EMHY
$590M
| $4.06M | ﹤0.01% |
80,974
+5,941
| +8% | +$299K |
2016 Q3
3 quarters
|
|
2465
Northern Trust STOXX Global ESG Select ETF
ESGG
$115M
| $4.06M | ﹤0.01% |
47,162
-25,940
| -35% | -$2.21M |
2016 Q3
3 quarters
|
|
|
EFF
2466
DELISTED
EATON VANCE FLOATING-RATE INCOME PLUS FUND
EFF
| $4.06M | ﹤0.01% |
241,849
+3,278
| +1% | +$56.2K |
2014 Q3
11 quarters
|
|
2467
Markel Group
MKL
$21.5B
| $4.05M | ﹤0.01% |
4,153
+3,040
| +273% | +$2.95M |
2013 Q2
16 quarters
|
|
|
NEWR
2468
DELISTED
New Relic, Inc.
NEWR
| $4.05M | ﹤0.01% |
94,229
+22,460
| +31% | +$935K |
2016 Q4
2 quarters
|
|
|
JOYY
2469
JOYY Inc
JOYY
$3.95B
| $4.05M | ﹤0.01% |
69,809
+10,444
| +18% | +$554K |
2015 Q4
6 quarters
|
|
|
CLVS
2470
DELISTED
Clovis Oncology, Inc.
CLVS
| $4.05M | ﹤0.01% |
43,215
-119,526
| -73% | -$7.31M |
2013 Q2
16 quarters
|
|
2471
Oil States International
OIS
$499M
| $4.04M | ﹤0.01% |
148,861
+114,724
| +336% | +$3.4M |
2013 Q2
16 quarters
|
|
2472
Corvus Pharmaceuticals
CRVS
$887M
| $4.03M | ﹤0.01% |
332,634
+178,658
| +116% | +$1.91M |
2016 Q2
4 quarters
|
|
|
AET
2473
PUT
DELISTED
Aetna Inc
AET
| $4.02M | ﹤0.01% |
26,500
-3,104,700
| -99% | -$439M |
2017 Q1
1 quarter
|
|
2474
CALL
Nucor
NUE
$57B
| $4.02M | ﹤0.01% |
+69,400
| New | +$4.07M |
2017 Q2
0 quarters
|
|
2475
Kforce
KFRC
$908M
| $4.01M | ﹤0.01% |
204,768
+106,810
| +109% | +$2.15M |
2015 Q4
6 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2017 Portfolio in Review
As of Q2 2017, JP Morgan Chase held 5,542 positions worth $438B, down 0.01% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2017 filing shows 462 new, 1,879 increased, 2,145 reduced and 563 closed positions. Its largest new stake was Altaba Inc: 12,081,650 shares worth $658M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $2.16B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2017 buy was Altaba Inc: 12,081,650 shares worth $658M.
- JP Morgan Chase added most to iShares Core MSCI EAFE ETF in Q2 2017, an estimated $2.04B increase.
- JP Morgan Chase's biggest Q2 2017 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $2.16B.
- JP Morgan Chase fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $439M.
- JP Morgan Chase's ten largest holdings make up 18% of its $438B portfolio in Q2 2017.
- JP Morgan Chase opened 462 new positions and closed 563 in Q2 2017.
- JP Morgan Chase's portfolio value fell 0.01% quarter-over-quarter to $438B.
Based on JP Morgan Chase's 13F filing for Q2 2017, filed 9 Aug 2017.